鎮痛剤の世界市場：薬剤クラス別（オピオイド、非オピオイド）、投与経路別（経口、局所、静脈内、経皮、直腸）、地域別－市場規模と予測、COVID-19影響分析、2028年までの予測

世界の鎮痛剤の市場規模は、2022年の516億3,000万米ドルから、2028年には675億5,000万米ドルになると予測されており、2023年から2028年までの予測期間中のCAGRは4.6%となっています。鎮痛剤を製造・販売する大手製造業の普及、市販薬の需要増加、局所鎮痛剤の需要増加、医療費の増加は、市場の成長を促進しています。

当レポートでは、世界の鎮痛剤市場について調査しており、市場分析、市場力学、企業プロファイルなど、包括的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 イントロダクション

• 鎮痛剤：概要
  • 鎮痛剤の使用
• 鎮痛剤のセグメンテーション：概要
  • 鎮痛剤のセグメンテーション

第3章 世界市場分析

• 世界の鎮痛剤市場：分析
  • 世界の鎮痛剤市場：概要
  • 世界の鎮痛剤市場：金額別
  • 世界の鎮痛剤市場：薬剤クラス別（オピオイド、非オピオイド）
  • 世界の鎮痛剤市場：投与チャネル別（経口、局所、静脈内、経皮、直腸）
  • 世界の鎮痛剤市場：地域別（北米、欧州、アジア太平洋、その他）
• 世界の鎮痛剤市場：薬剤クラス分析
  • 世界の鎮痛剤市場：概要：薬剤クラス別
  • 世界のオピオイド鎮痛剤市場：金額別
  • 世界の非オピオイド鎮痛剤市場：金額別
• 世界の鎮痛剤市場：投与チャネル分析
  • 世界の鎮痛剤市場：概要：投与チャネル別
  • 世界の経口鎮痛剤市場：金額別
  • 世界の局所鎮痛剤市場：金額別
  • 世界の静脈内鎮痛剤市場：金額別
  • 世界の経皮鎮痛剤市場：金額別
  • 世界の直腸鎮痛剤市場：金額別

第4章 地域市場分析

• 北米の鎮痛剤市場：分析
• 欧州の鎮痛剤市場：分析
• アジア太平洋の鎮痛剤市場：分析
• 世界のその他の地域の鎮痛剤市場：分析

第5章 新型コロナウイルス感染症（COVID-19）の影響

• COVID-19の影響
  • COVID-19が鎮痛剤市場に与える影響
  • COVID-19後の影響

第6章 市場力学

• 成長の促進要因
  • 急性慢性疾患の発生率の増加
  • 高齢者人口の増加
  • 医療費の急増
  • 可処分所得の増加
  • Eコマース販売の急増
  • 世界中の外科手術数の増加
  • 強力なアゴニストの需要の高まり
• 課題
  • 過剰摂取と依存症のリスク
  • 生物製剤の使用の増加
  • 医薬品開発の高額なコスト
• 市場動向
  • 鎮痛剤における人工知能の使用
  • 製薬分野における研究開発の急増
  • 製薬産業における戦略的提携と技術開発
  • より健康的なライフスタイル
  • RxからOTCへの切り替え

第7章 競合情勢

• 世界の鎮痛剤企業：市場シェア別
• 世界の全身性鎮痛剤企業：市場シェア別
• 世界の局所鎮痛剤企業：市場シェア別
• 西欧の鎮痛剤企業：市場シェア別
• 米国の局所鎮痛剤企業：市場シェア別
• 米国の全身性鎮痛剤企業：市場シェア別

第8章 企業プロファイル

• Bayer AG
• Sanofi S.A.
• Pfizer Inc.
• Abbott Laboratories
• Reckitt Benckiser Group PLC
• Johnson & Johnson
• Haleon PLC
• TEVA Pharmaceutical Industries Limited
• Sun Pharmaceutical Industries Ltd.
• Endo International Plc.
• GlaxoSmithKline Plc
• Eli Lilly and Company

List of Tables

• Table 1: Rx-to-OTC switches in the US list

List of Figures

• Figure 1: Uses of Analgesics
• Figure 2: Analgesics Segmentation
• Figure 3: Global Analgesics Market by Value; 2018-2022 (US$ Billion)
• Figure 4: Global Analgesics Market by Value; 2023-2028 (US$ Billion)
• Figure 5: Global Analgesics Market by Drug Class; 2022 (Percentage, %)
• Figure 6: Global Analgesics Market by Route of Administration; 2022 (Percentage, %)
• Figure 7: Global Analgesics Market by Region; 2022 (Percentage, %)
• Figure 8: Global Opioids Analgesics Market by Value; 2018-2022 (US$ Billion)
• Figure 9: Global Opioids Analgesics Market by Value; 2023-2028 (US$ Billion)
• Figure 10: Global Non Opioids Analgesics Market by Value; 2018-2022 (US$ Billion)
• Figure 11: Global Non Opioids Analgesics Market by Value; 2023-2028 (US$ Billion)
• Figure 12: Global Oral Analgesics Market by Value; 2018-2022 (US$ Billion)
• Figure 13: Global Oral Analgesics Market by Value; 2023-2028 (US$ Billion)
• Figure 14: Global Topical Analgesics Market by Value; 2018-2022 (US$ Billion)
• Figure 15: Global Topical Analgesics Market by Value; 2023-2028 (US$ Billion)
• Figure 16: Global Intravenous Analgesics Market by Value; 2018-2022 (US$ Billion)
• Figure 17: Global Intravenous Analgesics Market by Value; 2023-2028 (US$ Billion)
• Figure 18: Global Transdermal Analgesics Market by Value; 2018-2022 (US$ Billion)
• Figure 19: Global Transdermal Analgesics Market by Value; 2023-2028 (US$ Billion)
• Figure 20: Global Rectal Analgesics Market by Value; 2018-2022 (US$ Billion)
• Figure 21: Global Rectal Analgesics Market by Value; 2023-2028 (US$ Billion)
• Figure 22: North America Analgesics Market by Value; 2018-2022 (US$ Billion)
• Figure 23: North America Analgesics Market by Value; 2023-2028 (US$ Billion)
• Figure 24: North America Analgesics Market by Route of Administration; 2022 (Percentage, %)
• Figure 25: North America Topical and Others Analgesics Market by Value; 2021-2028 (US$ Billion)
• Figure 26: North America Analgesics Market by Region; 2022 (Percentage, %)
• Figure 27: The US Analgesics Market by Value; 2018-2022 (US$ Billion)
• Figure 28: The US Analgesics Market by Value; 2023-2028 (US$ Billion)
• Figure 29: Canada Analgesics Market by Value; 2018-2022 (US$ Billion)
• Figure 30: Canada Analgesics Market by Value; 2023-2028 (US$ Billion)
• Figure 31: Mexico Analgesics Market by Value; 2018-2022 (US$ Billion)
• Figure 32: Mexico Analgesics Market by Value; 2023-2028 (US$ Billion)
• Figure 33: Europe Analgesics Market by Value; 2018-2022 (US$ Billion)
• Figure 34: Europe Analgesics Market by Value; 2023-2028 (US$ Billion)
• Figure 35: Europe Analgesics Market by Route of Administration; 2022 (Percentage, %)
• Figure 36: Europe Topical and Others Analgesics Market by Value; 2021-2028 (US$ Billion)
• Figure 37: Europe Analgesics Market by Region; 2022 (Percentage, %)
• Figure 38: Germany Analgesics Market by Value; 2018-2022 (US$ Billion)
• Figure 39: Germany Analgesics Market by Value; 2023-2028 (US$ Billion)
• Figure 40: UK Analgesics Market by Value; 2018-2022 (US$ Billion)
• Figure 41: UK Analgesics Market by Value; 2023-2028 (US$ Billion)
• Figure 42: Italy Analgesics Market by Value; 2018-2022 (US$ Billion)
• Figure 43: Italy Analgesics Market by Value; 2023-2028 (US$ Billion)
• Figure 44: France Analgesics Market by Value; 2018-2022 (US$ Billion)
• Figure 45: France Analgesics Market by Value; 2023-2028 (US$ Billion)
• Figure 46: Spain Analgesics Market by Value; 2018-2022 (US$ Billion)
• Figure 47: Spain Analgesics Market by Value; 2023-2028 (US$ Billion)
• Figure 48: Rest of Europe Analgesics Market by Value; 2018-2022 (US$ Billion)
• Figure 49: Rest of Europe Analgesics Market by Value; 2023-2028 (US$ Billion)
• Figure 50: Asia Pacific Analgesics Market by Value; 2018-2022 (US$ Billion)
• Figure 51: Asia Pacific Analgesics Market by Value; 2023-2028 (US$ Billion)
• Figure 52: Asia Pacific Analgesics Market by Route of Administration; 2022 (Percentage, %)
• Figure 53: Asia Pacific Topical and Others Analgesics Market by Value; 2021-2028 (US$ Million)
• Figure 54: Asia Pacific Analgesics Market by Region; 2022 (Percentage, %)
• Figure 55: China Analgesics Market by Value; 2018-2022 (US$ Billion)
• Figure 56: China Analgesics Market by Value; 2023-2028 (US$ Billion)
• Figure 57: India Analgesics Market by Value; 2018-2022 (US$ Billion)
• Figure 58: India Analgesics Market by Value; 2023-2028 (US$ Billion)
• Figure 59: Japan Analgesics Market by Value; 2018-2022 (US$ Million)
• Figure 60: Japan Analgesics Market by Value; 2023-2028 (US$ Million)
• Figure 61: Australia Analgesics Market by Value; 2018-2022 (US$ Million)
• Figure 62: Australia Analgesics Market by Value; 2023-2028 (US$ Million)
• Figure 63: Rest of Asia Pacific Analgesics Market by Value; 2018-2022 (US$ Billion)
• Figure 64: Rest of Asia Pacific Analgesics Market by Value; 2023-2028 (US$ Billion)
• Figure 65: Rest of the World Analgesics Market by Value; 2018-2022 (US$ Billion)
• Figure 66: Rest of the World Analgesics Market by Value; 2023-2028 (US$ Billion)
• Figure 67: Global Number of People with Diabetes in Adults (20-79 Years) by Region; 2021 & 2045 (Million)
• Figure 68: Global Percentage of Population Aged 65 Years or Over; 2016, 2021 & 2050 (Percentage, %)
• Figure 69: The US Health Consumption Expenditure as a Percentage of GDP; 2016-2022 (Percentage, %)
• Figure 70: Global GNI per Capita; 2016-2021 (US$ Million)
• Figure 71: Global E-commerce as % of sales in Consumer Health; 2013-2021 (Percentage, %)
• Figure 72: Global Market Size for Artificial Intelligence in Healthcare; 2021-2030 (US $Billion)
• Figure 73: Global Pharmaceutical Research and Development Spending; 2019-2028 (US$ Billion)
• Figure 74: Global Analgesics Players by Market Share; 2022 (Percentage, %)
• Figure 75: Global Systemic Analgesics Players by Market Share; 2022 (Percentage, %
• Figure 76: Global Topical Analgesics Players by Market Share; 2022 (Percentage, %)
• Figure 77: Western Europe Analgesics Players by Market Share; 2022 (Percentage, %)
• Figure 78: The US Topical Analgesics Players by Market Share; 2022 (Percentage, %)
• Figure 79: The US Systemic Analgesics Players by Market Share; 2022 (Percentage, %)
• Figure 80: Bayer AG Net Sales by Segment; 2022 (Percentage, %)
• Figure 81: Sanofi S.A. Net Sales by Segments; 2022 (Percentage, %)
• Figure 82: Pfizer Inc. Revenue by Segment; 2022 (Percentage, %)
• Figure 83: Abbott Laboratories Revenue by Segment; 2022 (Percentage, %)
• Figure 84: Reckitt Benckiser Group PLC Net Revenue by Segment; 2022 (Percentage, %)
• Figure 85: Johnson & Johnson Sales by Business Segment; 2022 (Percentage, %)
• Figure 86: Haleon PLC Revenue by Segment; 2022 (Percentage, %)
• Figure 87: TEVA Pharmaceutical Industries Ltd., Revenues by Segment; 2021 (Percentage, %)
• Figure 88: Sun Pharmaceutical Industries Ltd. Revenue by Segment; 2022 (Percentage, %)
• Figure 89: Endo International Plc. Revenue by Segment; 2021 (Percentage, %)
• Figure 90: GlaxoSmithKline Plc. Sales by Products; 2022 (Percentage, %)
• Figure 91: Eli Lilly and Company Revenue by Products; 2022 (Percentage, %)

Analgesics are drugs that are used to relieve pain. They work by blocking or reducing the transmission of pain signals to the brain, or by altering the brain's perception of pain. There are several different types of analgesics, including nonsteroidal anti-inflammatory drugs (NSAIDs), acetaminophen, opioids, and local anesthetics. It is important to use analgesics only as directed and to follow the instructions on the label. Overuse or misuse of analgesics can lead to serious health problems, including liver damage, kidney damage, and addiction. In 2022, the global analgesics market was valued at US$51.63 billion, and is probable to reach US$67.55 billion by 2028.

The older population also has more frequent pain and aching issues, which helps the sector thrive. Also, technological improvements in pharmaceutical businesses to develop better analgesic medications are projected to generate profitable opportunities for the analgesic market in the future years. Moreover, rise of chronic pain, the prevalence of major manufacturing businesses that manufacture and sell analgesic pharmaceuticals, rising demand for over-the-counter drugs, increasing demand for topical analgesics, and rising healthcare spending all contribute to the market's growth. The global analgesics market value is projected to grow at a CAGR of 4.6%, during the forecast period of 2023-2028.

Market Segmentation Analysis:

By Drug Class: According to the report, the global analgesics market is segmented into two drug class: Opioids and Non-Opioids. Opioids segment acquired majority of share in the market in 2022. An increase in the prevalence of chronic diseases such as tuberculosis, arthritis, and cancer is expected to fuel the opioid segment's expansion during the forecast period. Furthermore, the industry is expanding because to opioids' anti-inflammatory, analgesic, and antipyretic characteristics.

By Route of Administration: According to the report, the global analgesics market is bifurcated into five route of administration: Oral, Topical, Intravenous, Transdermal and Rectal. Oral segment acquired majority of share in the market in 2022, as its approval of numerous over-the-counter (OTC) analgesics which do not require medication, the oral variety is gaining economic momentum with increased sales. Whereas, Intravenous segment is expected to have the highest CAGR in the future as Intravenous analgesics are popular with patients who need immediate pain relief because they provide rapid and effective pain relief. Also, the penetration of topical analgesics has been steadily rising over the past decade as they provide less invasive-pain reduction. As a result, people with a more active lifestyle, e.g. sports, have a higher use rate. The proportion of topical compared to other analgesics is the highest in Asia Pacific.

By Region: The report provides insight into the analgesics market based on the geographical operations, namely North America, Europe, Asia Pacific, and Rest of the World. North America analgesics market enjoyed the highest market share in 2022, primarily due to the rise in demand for non-opioid medications, the presence of key players, and the expansion of R&D activities across the healthcare sector in the region. Many people in the US rely on inadequate analgesics to treat muscular injuries and diseases. Thus, surging the growth of the US analgesics market.

Asia Pacific analgesics market is slated to become the most lucrative zone for the analgesics medication industry. Drug, made by GlaxoSmithKline Asia Private Limited (GSKAP), is the popular analgesics brand in India. With over two million tablets sold every day in India and over 20 tablets sold per second, it falls under the non-prescription (OTC) category. This alone is a major influencer in the Asia Pacific analgesics industry, supported greatly by the widespread practice of self-medication. China has been increasing its healthcare spending, leading to an increase in the availability of healthcare facilities, including pain management services. This has led to an increase in the demand for analgesics in China.

Global Analgesics Market Dynamics:

Growth Drivers: The rising incidence of acute chronic diseases such heart disease, cancer, diabetes, stroke, and arthritis is a primary reason driving up demand for analgesics medications. A surge in the prevalence of these medical conditions increases the demand for painkillers, which in turn is driving the analgesics market growth. Further, the market is expected to increase due to increasing geriatric population, upsurge in healthcare expenditure, increased disposable income, upsurge in e-commerce sales, rising number of medical surgeries across the world, rising demand for strong agonists, etc.

Challenges: Analgesics are potent drugs that can be beneficial in pain management, but they also carry the danger of major adverse effects, such as addiction and overdose. Overdose and addiction can occur with any form of painkiller, but opioids, which are a type of powerful agonist analgesic, provide a particularly significant danger. The other challenge that analgesics market faces is increasing use of biologics and high cost of drug development, etc.

Trends: A major trend gaining pace in analgesics market is use of artificial intelligence in analgesics. AI might potentially be utilized to help build more effective and individualized pain treatment solutions in the context of the analgesics market. AI could be used, for example, to analyze data from patient medical records, such as information on their pain symptoms, medical history, and other things that may be contributing to their pain. More trends in the market are believed to augment the growth of analgesics market during the forecasted period include, surge in research & development in pharmaceutical sector strategic collaborations and technological development in the pharmaceutical industry, healthier lifestyles, etc.

Impact Analysis of COVID-19 and Way Forward:

The global analgesics market was impacted by the COVID-19 outbreak. The pandemic had a favorable impact on the market, since increased focus on personal health encouraged purchases of these medications. The demand for over-the-counter cold and cough medicines was already high, and nutritional supplements were likely to expand at a faster rate due to COVID-19. Furthermore, the European Medicines Agency has advised using non-steroidal anti-inflammatories (NSAIDs) such as ibuprofen and paracetamol to treat moderate COVID-19 symptoms at the lowest dose possible. Additionally, because geriatric population are more vulnerable to infection due to weakening immune systems and the lack of a vaccine or therapy, the number of older persons infected with COVID-19 was considerable. Hence, all these factors increased the demand of analgesics market during the pandemic period.

Competitive Landscape and Recent Developments:

Global analgesics market is fragmented. Haleon is the clear global leader in the analgesics category. Haleon's global market share has been broadly flat over the past decade, which has included a period of modest market share declines until 2020 and then a sharp improvement over the last two years post the Rx-to-OTC switch of Voltaren in the US. Key players of global analgesics market are:

Bayer AG

Sanofi S.A.

Pfizer Inc.

Abbott Laboratories

Reckitt Benckiser Group PLC.

Johnson & Johnson

Haleon PLC

TEVA Pharmaceutical Industries Limited

Sun Pharmaceutical Industries Ltd.

Endo International Plc.

GlaxoSmithKline Plc

Eli Lilly and Company

The key players are constantly investing in strategic initiatives, such as new product launches, introducing their products to emerging markets and more, to maintain a competitive edge in this market. For instance, in April 2022, Abbott introduced a new version of its NeuroSphere my Path, a digital health app. With this launch, the company aimed to facilitate healthcare professionals to more precisely track their patients as they trial Abbott neurostimulation instruments in order to address the chronic pain issue in them. Moreover, this launch would also complement the connected care technology portfolio of the company.

Table of Contents

1. Executive Summary

2. Introduction

• 2.1 Analgesics: An Overview
  • 2.1.1 Uses of Analgesics
• 2.2 Analgesics Segmentation: An Overview
  • 2.2.1 Analgesics Segmentation

3. Global Market Analysis

• 3.1 Global Analgesics Market: An Analysis
  • 3.1.1 Global Analgesics Market: An Overview
  • 3.1.2 Global Analgesics Market by Value
  • 3.1.3 Global Analgesics Market by Drug Class (Opioids and Non Opioids)
  • 3.1.4 Global Analgesics Market by Route of Administration (Oral, Topical, Intravenous, Transdermal and Rectal)
  • 3.1.5 Global Analgesics Market by Region (North America, Europe, Asia Pacific and Rest of the World)
• 3.2 Global Analgesics Market: Drug Class Analysis
  • 3.2.1 Global Analgesics Market by Drug Class: An Overview
  • 3.2.2 Global Opioids Analgesics Market by Value
  • 3.2.3 Global Non Opioids Analgesics Market by Value
• 3.3 Global Analgesics Market: Route of Administration Analysis
  • 3.3.1 Global Analgesics Market by Route of Administration: An Overview
  • 3.3.2 Global Oral Analgesics Market by Value
  • 3.3.3 Global Topical Analgesics Market by Value
  • 3.3.4 Global Intravenous Analgesics Market by Value
  • 3.3.5 Global Transdermal Analgesics Market by Value
  • 3.3.6 Global Rectal Analgesics Market by Value

4. Regional Market Analysis

• 4.1 North America Analgesics Market: An Analysis
  • 4.1.1 North America Analgesics Market: An Overview
  • 4.1.2 North America Analgesics Market by Value
  • 4.1.3 North America Analgesics Market by Route of Administration (Topical and Others)
  • 4.1.4 North America Topical and Others Analgesics Market by Value
  • 4.1.5 North America Analgesics Market by Region (The US, Canada and Mexico)
  • 4.1.6 The US Analgesics Market by Value
  • 4.1.7 Canada Analgesics Market by Value
  • 4.1.8 Mexico Analgesics Market by Value
• 4.2 Europe Analgesics Market: An Analysis
  • 4.2.1 Europe Analgesics Market: An Overview
  • 4.2.2 Europe Analgesics Market by Value
  • 4.2.3 Europe Analgesics Market by Route of Administration (Topical and Others)
  • 4.2.4 Europe Topical and Others Analgesics Market by Value
  • 4.2.5 Europe Analgesics Market by Region (Germany, UK, Italy, France, Spain and Rest of Europe)
  • 4.2.6 Germany Analgesics Market by Value
  • 4.2.7 UK Analgesics Market by Value
  • 4.2.8 Italy Analgesics Market by Value
  • 4.2.9 France Analgesics Market by Value
  • 4.2.10 Spain Analgesics Market by Value
  • 4.2.11 Rest of Europe Analgesics Market by Value
• 4.3 Asia Pacific Analgesics Market: An Analysis
  • 4.3.1 Asia Pacific Analgesics Market: An Overview
  • 4.3.2 Asia Pacific Analgesics Market by Value
  • 4.3.3 Asia Pacific Analgesics Market by Route of Administration (Topical and Others)
  • 4.3.4 Asia Pacific Topical and Others Analgesics Market by Value
  • 4.3.5 Asia Pacific Analgesics Market by Region (China, India, Japan, Australia and Rest of Asia Pacific)
  • 4.3.6 China Analgesics Market by Value
  • 4.3.7 India Analgesics Market by Value
  • 4.3.8 Japan Analgesics Market by Value
  • 4.3.9 Australia Analgesics Market by Value
  • 4.3.10 Rest of Asia Pacific Analgesics Market by Value
• 4.4 Rest of the World Analgesics Market: An Analysis
  • 4.4.1 Rest of the World Analgesics Market: An Overview
  • 4.4.2 Rest of the World Analgesics Market by Value

5. Impact of COVID-19

• 5.1 Impact of COVID-19
  • 5.1.1 Impact of COVID-19 on Analgesics Market
  • 5.1.2 Post COVID-19 Impact

6. Market Dynamics

• 6.1 Growth Drivers
  • 6.1.1 Rising Incidence of Acute Chronic Diseases
  • 6.1.2 Increasing Geriatric Population
  • 6.1.3 Upsurge in Healthcare Expenditure
  • 6.1.4 Increased Disposable Income
  • 6.1.5 Upsurge in E-Commerce Sales
  • 6.1.6 Rising Number of Medical Surgeries across the World
  • 6.1.7 Rising Demand for Strong Agonists
• 6.2 Challenges
  • 6.2.1 Risk of Overdose and Addiction
  • 6.2.2 Increasing Use of Biologics
  • 6.2.3 High Cost of Drug Development
• 6.3 Market Trends
  • 6.3.1 Use of Artificial Intelligence in Analgesics
  • 6.3.2 Surge in Research & Development in Pharmaceutical Sector
  • 6.3.3 Strategic Collaborations and Technological Development in The Pharmaceutical Industry
  • 6.3.4 Healthier Lifestyles
  • 6.3.5 Rx-to-OTC switches

7. Competitive Landscape

• 7.1 Global Analgesics Players by Market Share
• 7.2 Global Systemic Analgesics Players by Market Share
• 7.3 Global Topical Analgesics Players by Market Share
• 7.4 Western Europe Analgesics Players by Market Share
• 7.5 The US Topical Analgesics Players by Market Share
• 7.6 The US Systemic Analgesics Players by Market Share

8. Company Profiles

• 8.1 Bayer AG
  • 8.1.1 Business Overview
  • 8.1.2 Operating Segments
  • 8.1.3 Business Strategy
• 8.2 Sanofi S.A.
  • 8.2.1 Business Overview
  • 8.2.2 Operating Segments
  • 8.2.3 Business Strategy
• 8.3 Pfizer Inc.
  • 8.3.1 Business Overview
  • 8.3.2 Business Segments
  • 8.3.3 Business Strategy
• 8.4 Abbott Laboratories
  • 8.4.1 Business Overview
  • 8.4.2 Operating Segment
  • 8.4.3 Business Strategy
• 8.5 Reckitt Benckiser Group PLC
  • 8.5.1 Business Overview
  • 8.5.2 Operating Segments
  • 8.5.3 Business Strategy
• 8.6 Johnson & Johnson
  • 8.6.1 Business Overview
  • 8.6.2 Business Segment
  • 8.6.3 Business Strategy
• 8.7 Haleon PLC
  • 8.7.1 Business Overview
  • 8.7.2 Operating Segments
  • 8.7.3 Business Strategy
• 8.8 TEVA Pharmaceutical Industries Limited
  • 8.8.1 Business Overview
  • 8.8.2 Operating Segments
  • 8.8.3 Business Strategy
• 8.9 Sun Pharmaceutical Industries Ltd.
  • 8.9.1 Business Overview
  • 8.9.2 Operating Segments
  • 8.9.3 Business Strategy
• 8.10 Endo International Plc.
  • 8.10.1 Business Overview
  • 8.10.2 Operating Segment
  • 8.10.3 Business Strategy
• 8.11 GlaxoSmithKline Plc
  • 8.11.1 Business Overview
  • 8.11.2 Sales by Products
  • 8.11.3 Business Strategies
• 8.12 Eli Lilly and Company
  • 8.12.1 Business Overview
  • 8.12.2 Revenue by Products
  • 8.12.3 Business Strategy